179 related articles for article (PubMed ID: 15630770)
1. AIDS-defining cancers in Western Europe, 1994-2001.
Ebrahim SH; Abdullah AS; McKenna M; Hamers FF
AIDS Patient Care STDS; 2004 Sep; 18(9):501-8. PubMed ID: 15630770
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma as a sexually transmissible infection: an analysis of Australian AIDS surveillance data. The National HIV Surveillance Committee.
Elford J; McDonald A; Kaldor J
AIDS; 1993 Dec; 7(12):1667-71. PubMed ID: 8286078
[TBL] [Abstract][Full Text] [Related]
4. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
5. Geography of AIDS-associated Kaposi's sarcoma in Europe.
Ebrahim SH; Peterman TA; Zaidi AA; Hamers FF
AIDS; 1997 Nov; 11(14):1739-45. PubMed ID: 9386809
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic malignancies and the acquired immunodeficiency syndrome.
Mueller N; Hatzakis A
Princess Takamatsu Symp; 1987; 18():159-71. PubMed ID: 3506539
[TBL] [Abstract][Full Text] [Related]
7. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
[TBL] [Abstract][Full Text] [Related]
8. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
9. AIDS-related Kaposi's sarcoma in Brazil: trends and geopolitical distribution.
Saraceni V; Talhari CC; Pereira GF; Golub JE; Talhari S; Miranda AE
Int J Dermatol; 2013 Dec; 52(12):1525-9. PubMed ID: 24134514
[TBL] [Abstract][Full Text] [Related]
10. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries.
Casabona J; Melbye M; Biggar RJ
Int J Cancer; 1991 Jan; 47(1):49-53. PubMed ID: 1985878
[TBL] [Abstract][Full Text] [Related]
12. The AIDS dilemma: drug diseases blamed on a passenger virus.
Duesberg P; Rasnick D
Genetica; 1998; 104(2):85-132. PubMed ID: 10220905
[TBL] [Abstract][Full Text] [Related]
13. Excess cancers among HIV-infected people in the United States.
Robbins HA; Pfeiffer RM; Shiels MS; Li J; Hall HI; Engels EA
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663691
[TBL] [Abstract][Full Text] [Related]
14. Trends in cancer risk among people with AIDS in the United States 1980-2002.
Engels EA; Pfeiffer RM; Goedert JJ; Virgo P; McNeel TS; Scoppa SM; Biggar RJ;
AIDS; 2006 Aug; 20(12):1645-54. PubMed ID: 16868446
[TBL] [Abstract][Full Text] [Related]
15. Malignant tumors and AIDS.
Nasti G; Vaccher E; Errante D; Tirelli U
Biomed Pharmacother; 1997; 51(6-7):243-51. PubMed ID: 9309244
[TBL] [Abstract][Full Text] [Related]
16. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
17. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
Shiels MS; Pfeiffer RM; Hall HI; Li J; Goedert JJ; Morton LM; Hartge P; Engels EA
JAMA; 2011 Apr; 305(14):1450-9. PubMed ID: 21486978
[TBL] [Abstract][Full Text] [Related]
18. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of AIDS-associated Kaposi's sarcoma in Italy.
Serraino D; Zaccarelli M; Franceschi S; Greco D
AIDS; 1992 Sep; 6(9):1015-9. PubMed ID: 1388890
[TBL] [Abstract][Full Text] [Related]
20. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
